Comfoderm ointment for external use 0.1%, 15 g
Expiration Date: 11/2025
Russian Pharmacy name:
Комфодерм мазь для наружного применения 0,1%, 15 г
Inflammatory skin diseases sensitive to therapy with topical glucocorticosteroids:
- atopic dermatitis, neurodermatitis, childhood eczema;
- true eczema;
- microbial eczema;
- simple contact dermatitis;
- allergic (contact) dermatitis;
- dyshidrotic eczema.
Apply externally 1 time / day with a thin layer on the affected area, rubbing slightly. Can be used with an occlusive dressing. Typically, the course of treatment for adults is no more than 12 weeks, and for children, no more than 4 weeks. Several courses of therapy are possible during the year.
Active ingredient: methylprednisolone aceponate (in terms of 100% substance) - 1 mg;
Additional components: liquid paraffin, petroleum jelly, white beeswax, castor bean seed oil.
- Tuberculous or syphilitic processes in the area of ??application of the drug; viral diseases (for example, chickenpox, shingles), in the area of ??application of the drug;
- rosacea, perioral dermatitis in the area of ??application of the drug; children's age up to 4 months;
- skin areas with manifestations of a reaction to vaccination; hypersensitivity to the components of the drug.
- Application during pregnancy and during breastfeeding
- If it is necessary to use the drug ComfodermЃ during pregnancy and during breastfeeding, the potential risk to the fetus and the expected benefits of treatment for the mother should be carefully weighed. During these periods, long-term use of the drug on extensive skin surfaces is not recommended; nursing mothers should not apply the drug to the mammary glands.
Pharmacological action of
GCS for external use. Suppresses the function of leukocytes and tissue macrophages. Limits the migration of leukocytes to the area of ??inflammation.
When applied topically and locally, the therapeutic activity of methylprednisolone is due to its anti-inflammatory, antiallergic and antiexudative (due to the vasoconstrictor effect) action.
Indications
Inflammatory skin diseases sensitive to therapy with topical glucocorticosteroids:
- atopic dermatitis, neurodermatitis, childhood eczema;
- true eczema;
- microbial eczema;
- simple contact dermatitis;
- allergic (contact) dermatitis;
- dyshidrotic eczema.
Contraindications
- Tuberculous or syphilitic processes in the area of ??application of the drug; viral diseases (for example, chickenpox, shingles), in the area of ??application of the drug;
- rosacea, perioral dermatitis in the area of ??application of the drug; children's age up to 4 months;
- skin areas with manifestations of a reaction to vaccination; hypersensitivity to the components of the drug.
- Use during pregnancy and during breastfeeding
- If you need to use the drug ComfodermЃ during pregnancy and during breastfeeding, you should carefully weigh the potential risk to the fetus and the expected benefits of treatment for the mother. During these periods, long-term use of the drug on extensive skin surfaces is not recommended; nursing mothers should not apply the drug to the mammary glands.
Dosage and administration
Apply externally 1 time / day with a thin layer on the affected area, rubbing slightly. Can be used with an occlusive dressing. Typically, the course of treatment for adults is no more than 12 weeks, and for children, no more than 4 weeks. Several courses of therapy are possible during the year.
Side effects
Skin and subcutaneous tissue disorders: rarely - perioral dermatitis, skin depigmentation, allergic reactions to the drug components; the frequency is unknown - skin atrophy, telangiectasia, striae, acne-like skin changes (when using the drug for more than 4 weeks and / or on an area of ??10% or more of the body surface).